Cagrilintide

🔬What Is Cagrilintide

Cagrilintide is a long-acting amylin receptor agonist — a next-gen analog of the hormone amylin, which is co-secreted with insulin. It works by slowing gastric emptying, increasing fullness, and regulating hunger signals at the brainstem level. Unlike GLP-1s alone, Cagrilintide attacks obesity from a complementary angle — and when stacked with Semaglutide, results are clinically superior to either compound alone.

📊Clinical Studies & Results

Cagrilintide has been evaluated in multiple Phase 2 and Phase 3 clinical trials:

• ▪REDEFINE 1 Phase 3 trial: CagriSema (Cagrilintide + Semaglutide) achieved 22.7% body weight loss vs 2.3% with placebo after 68 weeks
• ▪40.4% of CagriSema patients achieved ≥25% weight loss
• ▪Cagrilintide alone (2.4 mg) demonstrated 11.8% weight loss
• ▪As a long-acting amylin analogue, it mimics the natural satiety hormone produced by the pancreas
• ▪Well-tolerated with gastrointestinal side effects as the most common adverse events

Cagrilintide demonstrates significant and clinically relevant weight loss, especially when combined with GLP-1 receptor agonists, representing a dual-mechanism approach to obesity treatment.

🏆Benefits

• Enhances Satiety and Appetite Suppression – Feel full sooner, stay full longer
• Slows Gastric Emptying – Reduces meal size and snacking without willpower
• Amplifies Fat Loss When Combined With GLP-1s – Proven synergy with Semaglutide or Tirzepatide
• Improves Glycemic Control and Weight Regulation – Supports insulin and glucose balance
• Non-Stimulant, Low Side Effect Profile – No jitters, mood crashes, or hormonal suppression

⚠️Possible Side Effects

• ▪Gastrointestinal effects (nausea, decreased appetite) are dose-dependent—intended mechanism
• ▪Gradual dose titration minimizes adverse reactions
• ▪Significantly stronger appetite suppression than other GLP-1 agonists
• ▪May be combined with semaglutide for enhanced efficacy (CagriSema)
• ▪Adequate hydration essential; split doses for better tolerability

🎯Ideal For

• →Individuals struggling with hunger, food volume, or late-night eating
• →Users stacking with Semaglutide or Tirzepatide for maximum fat loss and appetite control
• →People needing long-term metabolic reset without stimulant abuse or diet rebound
• →Lifters or lifestyle clients aiming to cut body fat while maintaining performance and mood